Navigation Links
Andrew Technologies Obtains Patent for Visceral Lipectomy Application from USPTO
Date:2/6/2013

IRVINE, Calif., Feb. 6, 2013 /PRNewswire/ -- Andrew Technologies, LLC was issued a patent by the US Patent and Trademark Office (USPTO) that provides exclusivity for their Tissue Liquefaction Technology to be used for the removal of visceral fat; the dangerous and metabolically active fat that is attached to the intestines, liver, kidneys and other organs inside the body cavity. This application is currently under investigation by Andrew Technologies, and is not an FDA approved use for the new HydraSolve™ Lipoplasty System, which is cleared to remove subcutaneous fat.

HydraSolve™ is a novel liposuction device based on the same patented Tissue Liquefaction Technology™ that was launched in 2003 by Alcon as the AquaLase® Liquefaction Device, a modality on the Infiniti Vision System, for precision cataract surgery. HydraSolve™ combines natural saline solution with low levels of pressure and temperature, to liquefy only targeted fat tissue. Because fat tissue is liquefied, the cutting of fat by forceful thrusts of the cannula is no longer required. The specially designed HydraSolve™ cannula is manufactured with aperture edges that have a rounded radius of curvature that do not cut tissue.  It is the energized saline stream, inside the cannula, that liquefies targeted fat tissue while not liquefying or cutting blood vessels, nerves or connective tissue. HydraSolve™ achieves liquefaction of fat tissue by cell disaggregation, not by emulsification and the lysing of cell membranes.

Dr. Mark S. Andrew , who co-invented Tissue Liquefaction Technology™,  AquaLase® Liquefaction Device, and HydraSolve™ Lipoplasty System is the Founder and Chief Scientific Officer of Andrew Technologies and has been directly involved in all of the research and development of Tissue Liquefaction Technology for various treatments. According to Dr. Andrew, "the target tissue specificity of our non-cutting Tissue Liquefaction Technology may enable us to safely remove the visceral fat which surrounds the internal abdominal organs as well as the kidneys. Visceral lipectomy of those visceral fat stores, which constitutes the majority of visceral fat in the body, could be a very important future treatment option that may positively impact several of the most common medical problems in the world. We look forward to supporting the appropriate research to develop this exciting application of our liquefaction technology."

"Visceral fat has been recognized for its contribution to the metabolic syndrome and type 2 diabetes; but non-greater omentum visceral fat, the visceral fat which surrounds the internal organs in the abdomen as well as around the kidneys, has been virtually impossible to remove with existing technology. We are excited to participate in research that may one day allow us to potentially remove this harmful tissue" Said Dr. Noel N. Williams , Associate Professor of Clinical Surgery and Director, Penn Metabolic & Bariatric Surgery Program at The University of Pennsylvania.

About Andrew Technologies, LLC

Andrew Technologies, founded in 2007, is a medical technology company committed to improving patients' lives through body aesthetics and pursuit of surgical applications of Tissue Liquefaction Technology. Andrew Technologies is a venture capital funded company based in Orange County, CA and Haddonfield, NJ. Our primary investors are WFD Ventures http://www.wfdventures.com/ and NJTC Venture Fund http://www.njtcvc.com/.


'/>"/>
SOURCE Andrew Technologies, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GSK CEO Sir Andrew Witty Interviewed on Q2 2012 Results
2. Anaptysbio Expands Leadership Team With Addition Of Dr. Andrew J. Mcknight
3. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
4. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
5. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
6. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
7. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
8. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
9. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
10. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
11. MedClean Technologies Announces 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):